Financials Hydreight Technologies Inc.

Equities

NURS

CA44877L1013

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E. 09:30:00 2024-04-26 am EDT 5-day change 1st Jan Change
0.26 CAD 0.00% Intraday chart for Hydreight Technologies Inc. +4.00% -42.22%

Valuation

Fiscal Period: December 2020 2021 2022
Capitalization 1 - - 18.92
Enterprise Value (EV) 1 - - 16.51
P/E ratio - - -0.29 x
Yield - - -
Capitalization / Revenue - - 4.43 x
EV / Revenue - - 3.87 x
EV / EBITDA - - -10,296,781 x
EV / FCF - - 14,699,155 x
FCF Yield - - 0%
Price to Book - - -53 x
Nbr of stocks (in thousands) - - 37,843
Reference price 2 0.5174 0.7115 0.5000
Announcement Date 11/10/22 11/10/22 5/1/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022
Net sales 1 0.4527 1.199 4.268
EBITDA - - -1.603
EBIT 1 -0.2311 -0.5169 -1.621
Operating Margin -51.05% -43.1% -37.97%
Earnings before Tax (EBT) 1 -0.2311 -0.5169 -5.995
Net income 1 -0.2311 -0.5278 -5.995
Net margin -51.05% -44.01% -140.45%
EPS - - -1.700
Free Cash Flow - 0.1741 1.123
FCF margin - 14.52% 26.31%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 11/10/22 11/10/22 5/1/23
1CAD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022
Net Debt 1 - - -
Net Cash position 1 0.03 0.01 2.41
Leverage (Debt/EBITDA) - - -
Free Cash Flow - 0.17 1.12
ROE (net income / shareholders' equity) - 102% 1,051%
ROA (Net income/ Total Assets) - -137% -61%
Assets 1 - 0.3842 9.83
Book Value Per Share - - -0.0100
Cash Flow per Share - - 0.0600
Capex - - -
Capex / Sales - - -
Announcement Date 11/10/22 11/10/22 5/1/23
1CAD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. NURS Stock
  4. Financials Hydreight Technologies Inc.